|
TFG expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.601200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.407400E-01 |
| Normal-vs-Stage2 |
7.382800E-01 |
| Normal-vs-Stage3 |
4.025400E-01 |
| Normal-vs-Stage4 |
3.436300E-03 |
| Stage1-vs-Stage2 |
6.782400E-01 |
| Stage1-vs-Stage3 |
3.564400E-01 |
| Stage1-vs-Stage4 |
2.255200E-03 |
| Stage2-vs-Stage3 |
7.670800E-01 |
| Stage2-vs-Stage4 |
5.366100E-02 |
| Stage3-vs-Stage4 |
6.078300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.729800E-01 |
| Normal-vs-AfricanAmerican |
7.662000E-01 |
| Normal-vs-Asian |
4.445600E-01 |
| Caucasian-vs-AfricanAmerican |
7.332600E-01 |
| Caucasian-vs-Asian |
7.232800E-01 |
| AfricanAmerican-vs-Asian |
7.140800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.339400E-01 |
| Normal-vs-Female |
2.521200E-03 |
| Male-vs-Female |
6.226500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.363630E-01 |
| Normal-vs-Age(41-60Yrs) |
7.367800E-02 |
| Normal-vs-Age(61-80Yrs) |
7.201200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.297800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.074600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.153010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.198700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.573810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.355700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.261800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.413800E-01 |
| Normal-vs-Grade 2 |
8.092400E-01 |
| Normal-vs-Grade 3 |
5.148600E-01 |
| Normal-vs-Grade 4 |
2.296500E-02 |
| Grade 1-vs-Grade 2 |
6.239000E-01 |
| Grade 1-vs-Grade 3 |
7.216000E-01 |
| Grade 1-vs-Grade 4 |
3.999400E-01 |
| Grade 2-vs-Grade 3 |
6.840600E-01 |
| Grade 2-vs-Grade 4 |
2.248300E-02 |
| Grade 3-vs-Grade 4 |
4.492100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.180000E-01 |
| Normal-vs-ccB subtype |
3.379800E-02 |
| ccA subtype-vs-ccB subtype |
2.347600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.453040E-01 |
| Normal-vs-N1 |
9.336800E-03 |
| N0-vs-N1 |
7.700900E-03 |
|
|
